关注
Nunzia D'Onofrio
Nunzia D'Onofrio
PhD, Università degli Studi della Campania"Luigi Vanvitelli", dipartimento di Medicina di precisione
在 unicampania.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control?
C Sardu, N D’Onofrio, ML Balestrieri, M Barbieri, MR Rizzo, V Messina, ...
Diabetes care 43 (7), 1408-1415, 2020
4812020
SIRT1 and SIRT6 signaling pathways in cardiovascular disease protection
N D'Onofrio, L Servillo, ML Balestrieri
Antioxidants & redox signaling 28 (8), 711-732, 2018
3172018
Bioavailability of encapsulated resveratrol into nanoemulsion-based delivery systems
M Sessa, ML Balestrieri, G Ferrari, L Servillo, D Castaldo, N D’Onofrio, ...
Food chemistry 147, 42-50, 2014
2902014
Sirtuin 6 expression and inflammatory activity in diabetic atherosclerotic plaques: effects of incretin treatment
ML Balestrieri, MR Rizzo, M Barbieri, P Paolisso, N D’Onofrio, A Giovane, ...
Diabetes 64 (4), 1395-1406, 2015
1962015
Effects of metformin therapy on coronary endothelial dysfunction in patients with prediabetes with stable angina and nonobstructive coronary artery stenosis: the CODYCE …
C Sardu, P Paolisso, C Sacra, C Mauro, F Minicucci, M Portoghese, ...
Diabetes Care 42 (10), 1946-1955, 2019
1242019
Ergothioneine oxidation in the protection against high-glucose induced endothelial senescence: involvement of SIRT1 and SIRT6
N D’Onofrio, L Servillo, A Giovane, R Casale, M Vitiello, R Marfella, ...
Free Radical Biology and Medicine 96, 211-222, 2016
1202016
Sirtuins in vascular diseases: emerging roles and therapeutic potential
N D'Onofrio, M Vitiello, R Casale, L Servillo, A Giovane, ML Balestrieri
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1852 (7 …, 2015
1042015
Multiple pathways of SIRT6 at the crossroads in the control of longevity, cancer, and cardiovascular diseases
M Vitiello, A Zullo, L Servillo, FP Mancini, A Borriello, A Giovane, ...
Ageing research reviews 35, 301-311, 2017
972017
Does poor glycaemic control affect the immunogenicity of the COVID‐19 vaccination in patients with type 2 diabetes: the CAVEAT study
R Marfella, N D'Onofrio, C Sardu, L Scisciola, P Maggi, N Coppola, ...
Diabetes, Obesity and Metabolism 24 (1), 160-165, 2022
962022
Poor glycaemic control in type 2 diabetes patients reduces endothelial progenitor cell number by influencing SIRT1 signalling via platelet-activating factor receptor activation
ML Balestrieri, L Servillo, A Esposito, N D’onofrio, A Giovane, R Casale, ...
Diabetologia 56, 162-172, 2013
962013
Hyperglycaemia on admission to hospital and COVID-19
C Sardu, N D’Onofrio, ML Balestrieri, M Barbieri, MR Rizzo, V Messina, ...
Diabetologia 63, 2486-2487, 2020
912020
An uncommon redox behavior sheds light on the cellular antioxidant properties of ergothioneine
L Servillo, D Castaldo, R Casale, N D’Onofrio, A Giovane, D Cautela, ...
Free Radical Biology and Medicine 79, 228-236, 2015
892015
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte
N D’onofrio, L Scisciola, C Sardu, MC Trotta, M De Feo, C Maiello, ...
Cardiovascular diabetology 20 (1), 99, 2021
862021
Microplastics and nanoplastics in atheromas and cardiovascular events
R Marfella, F Prattichizzo, C Sardu, G Fulgenzi, L Graciotti, T Spadoni, ...
New England Journal of Medicine 390 (10), 900-910, 2024
832024
Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin
C Sardu, N D’Onofrio, M Torella, M Portoghese, F Loreni, S Mureddu, ...
Cardiovascular Diabetology 18, 1-11, 2019
802019
Ergothioneine antioxidant function: from chemistry to cardiovascular therapeutic potential
L Servillo, N D'Onofrio, ML Balestrieri
Journal of Cardiovascular Pharmacology 69 (4), 183-191, 2017
762017
Peri-procedural tight glycemic control during early percutaneous coronary intervention up-regulates endothelial progenitor cell level and differentiation during acute ST …
R Marfella, MR Rizzo, M Siniscalchi, P Paolisso, M Barbieri, C Sardu, ...
International Journal of Cardiology 168 (4), 3954-3962, 2013
732013
MicroRNA‐33 and SIRT1 influence the coronary thrombus burden in hyperglycemic STEMI patients
N D'Onofrio, C Sardu, P Paolisso, F Minicucci, F Gragnano, F Ferraraccio, ...
Journal of Cellular Physiology 235 (2), 1438-1452, 2020
682020
Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment
N D'Onofrio, C Sardu, MC Trotta, L Scisciola, F Turriziani, F Ferraraccio, ...
Molecular Metabolism 54, 101337, 2021
672021
Stachydrine ameliorates high‐glucose induced endothelial cell senescence and SIRT 1 downregulation
L Servillo, N D'Onofrio, L Longobardi, I Sirangelo, A Giovane, D Cautela, ...
Journal of cellular biochemistry 114 (11), 2522-2530, 2013
622013
系统目前无法执行此操作,请稍后再试。
文章 1–20